I. Lazarev

发表

Semi-automatic volumetric measurement of response to chemotherapy in lung cancer patients: How wrong are we using RECIST?

I. Shelef, S. Ariad, V. Greenberg, 2017, Lung Cancer.

Gefitinib In Pretreated Patients with Advanced Non- Small Cell Lung Cancer - Single Institution Experience

S. Ariad, I. Lazarev, J. Dudnik, 2006, Indian Journal of Medical and Paediatric Oncology.

Is Prostate Cancer Screening Justified in the Bedouin Population?

S. Ariad, I. Lazarev, W. Mermershtain, 2009, Oncology Research and Treatment.

CD20 Over-Expression in Hodgkin-Reed-Sternberg Cells of Classical Hodgkin Lymphoma: the Neglected Quest

D. Benharroch, K. Nalbandyan, I. Lazarev, 2015, Journal of Cancer.

Two Paraneoplastic Autoimmune Syndromes: Limbic Encephalitis and Palmar Fasciitis in a Patient with Small Cell Lung Cancer

I. Shelef, G. Ifergane, Y. Refaely, 2015, Rare tumors.

Breast cancer in Bedouin-Arab patients in southern Israel: epidemiologic and biologic features in comparison with Jewish patients.

D. Geffen, S. Ariad, I. Lazarev, 2014, Asian Pacific journal of cancer prevention : APJCP.

Adjuvant Aromatase Inhibitor Therapy in Patients with Stage I Breast Cancer at a Regional Oncology Center in Israel: Implementation of a ‘Switching' Policy in Postmenopausal Patients after Initial Tamoxifen

B. Delgado, S. Abu-Ghanem, D. Geffen, 2013, Oncology.

Toxic Epidermal Necrolysis Associated with Gemcitabine Therapy in a Patient with Metastatic Transitional Cell Carcinoma of the Bladder

S. Ariad, I. Lazarev, W. Mermershtain, 2003, Journal of chemotherapy.

Colorectal cancer in southern Israel: Comparison between Bedouin Arab and Jewish patients.

B. Kirshtein, S. Ariad, I. Lazarev, 2016, International journal of surgery.

Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study.

P. Blumenfeld, S. Tsuriel, H. Nechushtan, 2023, International journal of radiation oncology, biology, physics.